Rheumatoid Arthritis Clinical Trial
Official title:
A Randomized Controlled Study to Evaluate the Short- and Long-term Effectiveness of an Individualized Resource Oriented Occupational Therapy for Patients With Rheumatoid Arthritis
Verified date | February 2010 |
Source | University of Zurich |
Contact | n/a |
Is FDA regulated | No |
Health authority | Switzerland: Ethikkommission |
Study type | Interventional |
The purpose of the study is to compare the short- and long-term effectiveness of an individualized, resource-oriented joint protection intervention with the standard, problem-oriented joint protection intervention for patients with rheumatoid arthritis.
Status | Completed |
Enrollment | 54 |
Est. completion date | September 2009 |
Est. primary completion date | February 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Diagnosis of RA according to ACR Guidelines (1988) - Actual hand pain on activity or history of wrist and/or metacarpophalangeal(MCP) joint pain and inflammation - Referred to OT for a Joint Protection intervention program - Willingness to comply with the randomly assigned treatment and informed consent - Functional Class: 2 to 4 - German speaking/understanding/reading - Sufficient cognitive capacities to understand the aims and procedures of the proposed study and the requirements of participation Exclusion Criteria: - Functional class 1 (anticipated self-exclusion, as patients in class 1 will not be referred to JP). - Severe finger, hand, elbow or shoulder deformities - Insufficient ability to understand, speak and read the German language - Insufficient cognitive capacities to understand the aims and procedures of the proposed study and the requirements of participation. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Switzerland | University Hospital | Bern | |
Switzerland | Rehabilitation Clinic | Valens | |
Switzerland | Schulthess Klinik | Zurich | |
Switzerland | University Hospital | Zurich |
Lead Sponsor | Collaborator |
---|---|
University of Zurich | Gertrude und Wolfgang Schrader-Dislich Stiftung, Zurich, Switzerland, Swiss Ligue Against Rheumatism, Zurich, Switzerland, Zürcher Rheumastifung , Zurich, Switzerland |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | joint protection behavior | before/after intervention, 3,6,12 months follow up | No | |
Secondary | General quality of life | before intervention, 3,6,12 months follow up | No | |
Secondary | Health related quality of life / physical functional ability | before intervention, 6,12 months follow up | No | |
Secondary | Self-Illness Separation SIS, derived from the PRISM (intervention group) | before/during/after intervention, 3,6,12 months follow up | No | |
Secondary | Goals achievement (intervention group) | during/after intervention, 3,6,12 months follow up | No | |
Secondary | Hand impairment status, including pain | before/during/after intervention, 3,6,12 months follow up | No | |
Secondary | Arthritis self-efficacy and JP-specific self-efficacy | before/after intervention, 3,6,12 months follow up | No | |
Secondary | Self-perceived disease activity | before intervention, 12 months follow up | No | |
Secondary | Clinical data | before intervention, 3, 12 months follow up | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |